Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 16, 2023

Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) will conduct a conference call and webcast on February 16, 2023, at 8:00 a.m. ET to discuss its fourth quarter and year-end 2022 financial results. The management will also outline financial expectations for 2023 and provide company updates. Interested parties can access the webcast through Alkermes' website. U.S. callers can join by dialing +1 877 407 2988, while international callers can reach +1 201 389 0923. A replay will be available two hours post-event.

Positive

• The upcoming conference call allows investors to gain insights into financial performance and future expectations.

Negative

• No financial results or specific guidance for 2023 are provided in advance, potentially causing uncertainty among investors.

DUBLIN, Feb. 9, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Thursday, Feb. 16, 2023 to discuss the company's fourth quarter and year-end 2022 financial results. Management will also discuss financial expectations for 2023 and provide an update on the company.

The webcast player and accompanying slides may be accessed on the Investors section of Alkermes' website at www.alkermes.com. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers. A replay of the webcast will be available approximately two hours after the completion of the event and may be accessed by visiting Alkermes' website. 

About Alkermes plc
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:
Jamie Bernard
Investor Relations
+1 781 873 2402

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-16-2023-301743184.html

SOURCE Alkermes plc

FAQ

When will Alkermes report its fourth quarter and year-end 2022 financial results?

Alkermes will report its financial results on February 16, 2023.

How can I access the Alkermes conference call?

You can access the conference call by visiting Alkermes' website or dialing +1 877 407 2988 for U.S. callers.

What topics will be discussed during Alkermes' conference call?

Management will discuss the fourth quarter and year-end 2022 financial results and provide financial expectations for 2023.

Is there a replay available for the Alkermes conference call?

Yes, a replay will be available approximately two hours after the event on Alkermes' website.